These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1259 related items for PubMed ID: 16572401
1. Nonsmall cell lung cancer presenting with synchronous solitary brain metastasis. Hu C, Chang EL, Hassenbusch SJ, Allen PK, Woo SY, Mahajan A, Komaki R, Liao Z. Cancer; 2006 May 01; 106(9):1998-2004. PubMed ID: 16572401 [Abstract] [Full Text] [Related]
8. Management and prognosis in synchronous solitary resected brain metastasis from non-small-cell lung cancer. Louie AV, Rodrigues G, Yaremko B, Yu E, Dar AR, Dingle B, Vincent M, Sanatani M, Younus J, Malthaner R, Inculet R. Clin Lung Cancer; 2009 May 01; 10(3):174-9. PubMed ID: 19443337 [Abstract] [Full Text] [Related]
9. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases]. Cai Y, Wang WL, Xu B, Zhu GY, Zhang SW. Ai Zheng; 2006 Nov 01; 25(11):1419-22. PubMed ID: 17094913 [Abstract] [Full Text] [Related]
12. Primary chemotherapy for newly diagnosed nonsmall cell lung cancer patients with synchronous brain metastases compared with whole-brain radiotherapy administered first : result of a randomized pilot study. Lee DH, Han JY, Kim HT, Yoon SJ, Pyo HR, Cho KH, Shin SH, Yoo H, Lee SH, Lee JS. Cancer; 2008 Jul 01; 113(1):143-9. PubMed ID: 18459180 [Abstract] [Full Text] [Related]
15. Number of metastatic sites is a strong predictor of survival in patients with nonsmall cell lung cancer with or without brain metastases. Oh Y, Taylor S, Bekele BN, Debnam JM, Allen PK, Suki D, Sawaya R, Komaki R, Stewart DJ, Karp DD. Cancer; 2009 Jul 01; 115(13):2930-8. PubMed ID: 19441110 [Abstract] [Full Text] [Related]
16. Brain metastases in breast cancer: prognostic factors and management. Lee SS, Ahn JH, Kim MK, Sym SJ, Gong G, Ahn SD, Kim SB, Kim WK. Breast Cancer Res Treat; 2008 Oct 01; 111(3):523-30. PubMed ID: 17990100 [Abstract] [Full Text] [Related]
17. Lung cancer and its operable brain metastasis: survival rate and staging problems. Furák J, Troján I, Szöke T, Agócs L, Csekeö A, Kas J, Svastics E, Eller J, Tiszlavicz L. Ann Thorac Surg; 2005 Jan 01; 79(1):241-7; discussion 241-7. PubMed ID: 15620950 [Abstract] [Full Text] [Related]
18. Phase III study of efaproxiral as an adjunct to whole-brain radiation therapy for brain metastases. Suh JH, Stea B, Nabid A, Kresl JJ, Fortin A, Mercier JP, Senzer N, Chang EL, Boyd AP, Cagnoni PJ, Shaw E. J Clin Oncol; 2006 Jan 01; 24(1):106-14. PubMed ID: 16314619 [Abstract] [Full Text] [Related]
19. Does the incidence and outcome of brain metastases in locally advanced non-small cell lung cancer justify prophylactic cranial irradiation or early detection? Carolan H, Sun AY, Bezjak A, Yi QL, Payne D, Kane G, Waldron J, Leighl N, Feld R, Burkes R, Keshavjee S, Shepherd F. Lung Cancer; 2005 Jul 01; 49(1):109-15. PubMed ID: 15949596 [Abstract] [Full Text] [Related]
20. Recursive partitioning analysis (RPA) class does not predict survival in patients with four or more brain metastases. Nieder C, Andratschke N, Grosu AL, Molls M. Strahlenther Onkol; 2003 Jan 01; 179(1):16-20. PubMed ID: 12540980 [Abstract] [Full Text] [Related] Page: [Next] [New Search]